Tag: neurointerventions
Crossroads announces positive early clinical performance during Path BGC’s limited market...
Crossroads Neurovascular today announced successful early clinical experiences with its newly US Food and Drug Administration (FDA)-cleared Path balloon guide catheter (BGC) during the...

